(Q30612949)
Statements
1 reference
Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data (English)
1 reference
Eiji Kurosaki
1 reference
Hideaki Ogasawara
1 reference
4 April 2013
1 reference
1 reference
139
1 reference
51-59
1 reference
Identifiers
1 reference
1 reference